MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC grew its holdings in MeiraGTx Holdings plc (NASDAQ:MGTX - Free Report) by 16.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 570,646 shares of the company's stock after purchasing an additional 80,407 shares during the quarter. Geode Capital Management LLC owned approximately 0.73% of MeiraGTx worth $3,475,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of MGTX. China Universal Asset Management Co. Ltd. grew its position in shares of MeiraGTx by 11.3% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 16,571 shares of the company's stock valued at $101,000 after purchasing an additional 1,685 shares during the last quarter. PUREfi Wealth LLC acquired a new stake in shares of MeiraGTx in the fourth quarter valued at approximately $122,000. SG Americas Securities LLC grew its position in shares of MeiraGTx by 13.3% in the fourth quarter. SG Americas Securities LLC now owns 22,240 shares of the company's stock valued at $135,000 after purchasing an additional 2,617 shares during the last quarter. Corebridge Financial Inc. grew its position in shares of MeiraGTx by 11.6% in the fourth quarter. Corebridge Financial Inc. now owns 23,147 shares of the company's stock valued at $141,000 after purchasing an additional 2,405 shares during the last quarter. Finally, Rhumbline Advisers grew its position in shares of MeiraGTx by 12.3% in the fourth quarter. Rhumbline Advisers now owns 54,891 shares of the company's stock valued at $334,000 after purchasing an additional 5,993 shares during the last quarter. 67.48% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at MeiraGTx

In related news, CFO Richard Giroux sold 24,000 shares of the company's stock in a transaction on Tuesday, April 22nd. The stock was sold at an average price of $6.00, for a total value of $144,000.00. Following the completion of the transaction, the chief financial officer now directly owns 882,494 shares in the company, valued at approximately $5,294,964. This represents a 2.65 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Alexandria Forbes sold 47,500 shares of the business's stock in a transaction dated Tuesday, April 8th. The shares were sold at an average price of $5.34, for a total value of $253,650.00. Following the sale, the chief executive officer now directly owns 1,408,983 shares of the company's stock, valued at approximately $7,523,969.22. This trade represents a 3.26 % decrease in their position. The disclosure for this sale can be found here. Insiders own 8.40% of the company's stock.

MeiraGTx Stock Performance

MeiraGTx stock opened at $6.70 on Monday. The firm has a market capitalization of $528.33 million, a P/E ratio of -5.54, a PEG ratio of 0.37 and a beta of 1.21. The stock has a fifty day moving average price of $6.54 and a 200 day moving average price of $6.32. MeiraGTx Holdings plc has a 52 week low of $3.85 and a 52 week high of $8.75. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.86.

MeiraGTx (NASDAQ:MGTX - Get Free Report) last released its earnings results on Thursday, March 13th. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.48) by ($0.02). The business had revenue of $21.39 million during the quarter, compared to analyst estimates of $1.50 million. MeiraGTx had a negative net margin of 633.05% and a negative return on equity of 146.38%. Equities research analysts anticipate that MeiraGTx Holdings plc will post -1.48 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have recently commented on MGTX shares. Royal Bank of Canada increased their price target on shares of MeiraGTx from $11.00 to $13.00 and gave the company an "outperform" rating in a research report on Monday, March 17th. Chardan Capital reiterated a "buy" rating and issued a $36.00 price target on shares of MeiraGTx in a report on Monday, February 24th.

About MeiraGTx

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.